Literature DB >> 31568067

Area Deprivation as a Risk Factor for Methicillin-resistant Staphylococcus aureus Infection in Pediatric Cystic Fibrosis.

Gabriela R Oates1,2, William T Harris1,2, Steven M Rowe1,2,3, George M Solomon2,3, Suranjana Dey4, Aowen Zhu1, Wynton C Hoover1, Hector H Gutierrez1,2.   

Abstract

BACKGROUND: In US cystic fibrosis (CF) patients, methicillin-resistant Staphylococcus aureus (MRSA) rates have tripled in the past 2 decades. Known clinical risk factors include exposure to a healthcare setting, Pseudomonas aeruginosa and CF-related diabetes. Area-level socio-environmental exposures have not been evaluated. We explored the association of area-level deprivation with MRSA prevalence in a pediatric CF Center in the Southeastern United States.
METHODS: Patients' residential addresses were geocoded and linked to a composite Area Deprivation Index and Rural-Urban Commuting Area scores. The association of MRSA with Area Deprivation Index and Rural-Urban Commuting Area scores was evaluated using logistic regression with robust standard errors adjusted for sociodemographic covariates (age, sex, race, mother's and father's education and household income), clinical risk factors (P. aeruginosa, CF-related diabetes, hospitalizations and number of clinic visits) and clustering.
RESULTS: The study included all pediatric patients (N = 231; mean age 12) at a single CF Center. MRSA was present in 44% of subjects. Higher area-level deprivation was correlated with rural residence, lack of parental college education and lower household income (P < 0.001 for each). In a multiple regression model fully adjusted for patient-level sociodemographic covariates, clinical risk factors and clustering, neighborhood deprivation was associated with more than 2-fold increase in the odds of having MRSA [OR 2.26 (1.14-4.45), P < 0.05].
CONCLUSIONS: Neighborhood deprivation is a risk factor for MRSA in pediatric CF, doubling the odds of infection. Community-level socioeconomic risk factors should be considered when developing prevention strategies and treatment plans for MRSA infection in pediatric patients with CF.

Entities:  

Mesh:

Year:  2019        PMID: 31568067      PMCID: PMC6802275          DOI: 10.1097/INF.0000000000002419

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  43 in total

1.  Air pollution, health and social deprivation: A fine-scale risk assessment.

Authors:  Xavier Morelli; Camille Rieux; Josef Cyrys; Bertil Forsberg; Rémy Slama
Journal:  Environ Res       Date:  2016-02-05       Impact factor: 6.498

2.  Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.

Authors:  Nada S Harik; Gulnur Com; Xinyu Tang; Maria Melguizo Castro; Mary E Stemper; John L Carroll
Journal:  Am J Infect Control       Date:  2015-12-09       Impact factor: 2.918

3.  Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.

Authors:  Marianne S Muhlebach; Sonya L Heltshe; Elena B Popowitch; Melissa B Miller; Valeria Thompson; Margaret Kloster; Thomas Ferkol; Wynton C Hoover; Michael S Schechter; Lisa Saiman
Journal:  Ann Am Thorac Soc       Date:  2015-06

4.  Area Deprivation Index Predicts Readmission Risk at an Urban Teaching Hospital.

Authors:  Jianhui Hu; Amy J H Kind; David Nerenz
Journal:  Am J Med Qual       Date:  2018-01-22       Impact factor: 1.852

5.  Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Authors:  Don B Sanders; Rachel C L Bittner; Margaret Rosenfeld; Lucas R Hoffman; Gregory J Redding; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

6.  Tobacco-smoke exposure in children who live in multiunit housing.

Authors:  Karen M Wilson; Jonathan D Klein; Aaron K Blumkin; Mark Gottlieb; Jonathan P Winickoff
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

7.  Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

Authors:  Elliott C Dasenbrook; William Checkley; Christian A Merlo; Michael W Konstan; Noah Lechtzin; Michael P Boyle
Journal:  JAMA       Date:  2010-06-16       Impact factor: 56.272

8.  Health inequalities and cystic fibrosis.

Authors:  David Taylor-Robinson; Michael S Schechter
Journal:  BMJ       Date:  2011-08-23

9.  A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010.

Authors:  J A Casey; S E Cosgrove; W F Stewart; J Pollak; B S Schwartz
Journal:  Epidemiol Infect       Date:  2013-04-23       Impact factor: 2.451

10.  Are neighborhood-level characteristics associated with indoor allergens in the household?

Authors:  Lindsay Rosenfeld; Rima Rudd; Ginger L Chew; Karen Emmons; Dolores Acevedo-García
Journal:  J Asthma       Date:  2010-02       Impact factor: 2.515

View more
  5 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

2.  Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Ann Am Thorac Soc       Date:  2021-02

3.  Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors.

Authors:  Dana Albon; Aricca D Van Citters; Thida Ong; Olivia Dieni; Christopher Dowd; Anne Willis; Kathryn A Sabadosa; Peter Scalia; Kimberly Reno; Gabriela R Oates; Michael S Schechter
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

Review 4.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

5.  Association between insurance variability and early lung function in children with cystic fibrosis.

Authors:  Kimberly M Dickinson; Kevin J Psoter; Kristin A Riekert; Joseph M Collaco
Journal:  J Cyst Fibros       Date:  2021-06-24       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.